5,6-Dimethylthieno[2,3-d]pyrimidin-4(3H)-one, 95.0%, 5g

(2S)-2-METHYL-5-PHENYLPYRROLIDINE, 95.0%, 500mg

Hydroxyvalerenic acid, with analyt. Documents, 100 mg, glass packaging

4-((3-Bromo-4-methylphenyl)sulfonyl)morpholine, 95.0%, 1g

6-fluoro-1,3-benzoxazol-2(3H)-one, 95.0%, 25g

4-Cyanobenzylamine, 98.0%, 100g

Phenylpyruvic Acid>93.0%(GC)(T)5g

Trimethylsilyl iodide (stabilised with 0.1% Copper), 98%, 100g

(4R)-3,4-Dimethyl-1,3-oxazolidine-2,5-dione, 98%, 25g

4-Ethoxy-3-methylbenzaldehyde, 95.0%, 1g

Dansyl-L-leucine, 98%, 1g

4-Chloro-5-phenyl-[1,2,3]dithiazol-2-ylium; chloride, 95.0%, 1g

2-(1-Aminocyclopentyl)acetonitrile, 95.0%, 100mg